Logo

Your free order overview

You currently have not items to display
Logo

Your contact details

This is a required field

Logo

Thank you!

Thank you for choosing Janssen Medical Cloud for ordering your materials.

Importance of Testing/Retesting & Impact for Family

58-year-old male referred for genetic testing for retinitis pigmentosa

Suspected clinical diagnosis: Retinitis pigmentosa (RP)

Presenting complaint: Seeing low vision specialist for reduced visual acuity, both eyes

Medical history: No significant systemic medical problems

Family history: It is apparent from the pedigree chart that the retinal disease is consistent with an X-linked recessive condition

Eye exam and imaging

  • Bone spicule pattern in the retina
  • Visual acuity: hand motion OD; 20/200 OS
  • Visual field: severely constricted—less than 5 degrees, both eyes

Additional information: Patient had prior genetic testing with an inherited retinal disease (IRD) panel (~300 genes) that identified 2 variants of uncertain significance; 1 in USH2A and 1 in WDR19

  • Based on the pedigree, an X-linked cause of the disease was most likely the case. However, RPGR, the most common cause of the X-linked type of RP, was not included on the prior test

Genetic test: Retested in a different lab with the RPGR gene included on the panel

Genetic result: Positive for pathogenic variant in RPGR (c2236_2237del; p.Glu746Argfs*23)

Final diagnosis: X-linked retinitis pigmentosa (XLRP)

Key Takeaways

This patient received a prior genetic test revealing an inconclusive result because the initial genetic testing panel was not inclusive of the RPGR gene. Genetic testing panels can vary by lab,[1] further demonstrating the necessity of ensuring the inclusivity of suspected IRD genes in a genetic testing panel. With a confirmed result, the patient’s family members were recommended to perform further testing via targeted variant analysis.

OD=oculus dexter (right eye); OS=oculus sinister (left eye).

This case study is based on a licensed genetic counsellor's in-office experience. It is based on a real patient with changes made for privacy considerations.

CP-448309 - May 2024